Healthy Extracts (HYEX) Cash from Operations Growth (1y) (2016 - 2025)
Healthy Extracts (HYEX) Cash from Operations Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 779.11% |
| Sep 30, 2025 | -635.32% |
| Jun 30, 2025 | -89.82% |
| Mar 31, 2025 | 220.56% |
| Dec 31, 2024 | -24.71% |
| Sep 30, 2024 | 177.02% |
| Jun 30, 2024 | 378.94% |
| Mar 31, 2024 | 105.46% |
| Dec 31, 2023 | 137.85% |
| Sep 30, 2023 | 21.38% |
| Jun 30, 2023 | -23.93% |
| Mar 31, 2023 | -216.28% |
| Dec 31, 2022 | -459.52% |
| Sep 30, 2022 | 68.41% |
| Jun 30, 2022 | -45.51% |
| Mar 31, 2022 | 82.93% |
| Dec 31, 2021 | -95.85% |
| Sep 30, 2021 | 73.82% |
| Jun 30, 2021 | 97.99% |
| Mar 31, 2021 | -262.19% |